Myriad Genetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.About MYGN
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A.
MYGN Key Statistics
Stock Snapshot
The current Myriad Genetics(MYGN) stock price is $4.07, with a market capitalization of 378.27M. The stock trades at a price-to-earnings (P/E) ratio of -0.92.
On 2026-05-31, Myriad Genetics(MYGN) stock traded between a low of $3.93 and a high of $4.27. Shares are currently priced at $4.07, which is +3.7% above the low and -4.7% below the high.
The Myriad Genetics(MYGN)'s current trading volume is 5.75M, compared to an average daily volume of 2.01M.
In the last year, Myriad Genetics(MYGN) shares hit a 52-week high of $8.59 and a 52-week low of $3.53.
In the last year, Myriad Genetics(MYGN) shares hit a 52-week high of $8.59 and a 52-week low of $3.53.
MYGN News
Myriad Genetics, Inc. MYGN recently announced that it would launch the Prolaris + AI Test at the end of this month. It will be the first prostate cancer biomark...
Myriad Genetics (MYGN) announced the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the first and only prostate cancer biomarker te...
Analyst ratings
60%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.